Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study

Neurology. 1998 Sep;51(3):742-7. doi: 10.1212/wnl.51.3.742.

Abstract

Background: The major histocompatibility complex (MHC) has been consistently associated with susceptibility to MS and the course of several other human autoimmune diseases. A putative association between the course and severity of MS and the MHC remains controversial.

Methods: DR and DQ genotyping by either restriction fragment length polymorphism or sequence-specific PCR-based typing in 119 patients representing 73.4% of the population with MS evaluated in a cross-sectional disability survey and 100 healthy controls from Olmsted County, Minnesota.

Results: We found a positive association between MS susceptibility and the DR15-DQ6 and DR13-DQ7 haplotypes, and we found a negative association with the DR1-DQ5 haplotype. We found a trend to a positive association of primary progressive MS with DR4-DQ8 and DR1-DQ5 and an association of "bout onset" MS with DR17-DQ2. We did not find an association with disease severity, as defined by EDSS/duration.

Conclusion: Lack of consistency between different studies may be due to regional variation in MS and limitations of power but likely indicate a minor effect of MHC class II genes on the course and severity of MS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alleles
  • Cross-Sectional Studies
  • Disease Susceptibility
  • Female
  • Genes, MHC Class II / genetics*
  • Genotype
  • HLA-DQ Antigens / genetics
  • HLA-DR Antigens / genetics
  • Haplotypes
  • Humans
  • Male
  • Minnesota
  • Multiple Sclerosis / diagnosis
  • Multiple Sclerosis / genetics*
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length
  • Prognosis

Substances

  • HLA-DQ Antigens
  • HLA-DR Antigens